Serena Tongiani

Indena

Serena Tongiani graduated from University Perugia, Italy, with a diploma in Pharmaceutical Science and a PhD in Chemistry and Pharmaceutical Science from University of Urbino, Italy. From 2002 to 2005 she worked at the University of Kansas as research associate conducting research on new drug delivery technologies. In 2005 Dr. Tongiani joint Schering Plough Corporation in the US headquarters and started to work in the oral and solid formulation product development group. In 2008 she took over the responsibility of the anti-inflammatory drug development group in Merck where she was engaged in the setup of the phase III studies for one of Merck major drug candidates. In 2010 she took over the position of Head of Preclinical Development departments in ACRAF, Angelini. In May 2011, Serena became R&D Director and in 2015 she was appointed Chief Scientific Officer with an overall responsibility for the company portfolio development, supervising also the Business Development and Regulatory Affairs activities. In 2021 Serena accepted the position of Chief Portfolio Officer in Indena leading company dedicated to the identification, development and production of high quality active principles from plants, for pharma and healthfood.